(Q43037902)

12 November 2017

title

Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases (English)

1 reference

12 November 2017

main subject

visceral leishmaniasis

1 reference

1 reference

Sujay Khandpur

1

1 reference

12 November 2017

Pankaj Chaturvedi

2

1 reference

12 November 2017

Uttam Kumar

3

1 reference

12 November 2017

Binod K Khaitan

4

1 reference

12 November 2017

Jyotish C Samantaray

5

1 reference

12 November 2017

Vinod K Sharma

6

1 reference

12 November 2017

publication date

1 May 2010

1 reference

International Journal of Dermatology

12 November 2017

published in

1 reference

12 November 2017

volume

49

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

565-569

1 reference

Drug resistance in leishmaniasis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Trial of oral miltefosine for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Chemotherapy of leishmaniasis: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Oral miltefosine for Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Treatment of leishmaniasis with miltefosine: 2008 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2010.04326.X

10.1111/J.1365-4632.2010.04326.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference